Edgewise Therapeutics Q4 EPS $(0.47) Misses $(0.43) Estimate
Portfolio Pulse from Benzinga Newsdesk
Edgewise Therapeutics (NASDAQ:EWTX) reported a Q4 EPS loss of $(0.47), missing the consensus estimate of $(0.43) by 9.3%. This represents a 51.61% increase in losses compared to the same period last year.
February 22, 2024 | 1:09 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Edgewise Therapeutics reported a larger than expected Q4 loss, missing analyst estimates.
Missing earnings estimates, especially with a significant increase in losses year-over-year, typically leads to negative investor sentiment in the short term. This could result in a decrease in stock price as the market adjusts to the new information.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100